Seed Round - Lys Therapeutics

Seed Round - Lys Therapeutics

Investment Firm

Overview

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

Announced Date

Nov 14, 2022

Funding Type

Seed

Highlights

Location

Europe

Social

Investor Lead

HTH

HTH

HTH is a early_stage_venture firm.

Participant Investors

1

Investor Name
Participant InvestorHTH

Round Details and Background

Lys Therapeutics raised $3095950 on 2022-11-14 in Seed Round

Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 14, 2022
Debt Financing - Lys Therapeutics
1-2.6M
Mar 15, 2023
Grant - Lys Therapeutics
1-600.0K
Mar 31, 2021
Non Equity Assistance - Lys Therapeutics
2-undefined
May 15, 2023
Non Equity Assistance - Lys Therapeutics
1-undefined

Recent Activity

There is no recent news or activity for this profile.